Largest Drug Manufacturers - General Companies by Market Cap
The Drug Manufacturers - General sector has 87 publicly listed stocks with a combined market cap of $7.20 Trillion. Eli Lilly and Company leads the sector with a market cap of $936.50 Billion. This ranking covers all Drug Manufacturers - General stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
$7.20 Trillion
Companies Listed
87
Largest Company
Eli Lilly and …
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 1 |
Eli Lilly and Company
NYSE:LLY |
$936.50 Billion | $936.50 Billion | USA | $1169.86 | +4.86% | -4.16% | 55.48 Million |
| 2 |
Eli Lilly and Company
SA:LILY34 |
$853.51 Billion | R$4.35 Trillion | Brazil | R$153.70 | +0.70% | -0.16% | 250.45K |
| 3 |
Johnson & Johnson
NYSE:JNJ |
$574.95 Billion | $574.95 Billion | USA | $257.59 | +1.04% | -3.43% | 172.74 Million |
| 4 |
AbbVie Inc
NYSE:ABBV |
$356.49 Billion | $356.49 Billion | USA | $246.20 | +0.98% | -6.46% | 120.89 Million |
| 5 |
Merck & Company Inc
NYSE:MRK |
$298.26 Billion | $298.26 Billion | USA | $128.33 | +0.26% | -2.65% | 212.80 Million |
| 6 |
Novartis AG
MX:NVSN |
$297.59 Billion | MX$5.17 Trillion | Mexico | MX$2710.00 | -0.88% | -1.17% | 2.61K |
| 7 |
AstraZeneca PLC
MX:AZNN |
$290.50 Billion | MX$5.05 Trillion | Mexico | MX$1628.00 | +1.25% | -4.81% | 6.50K |
| 8 |
AstraZeneca PLC
NASDAQ:AZN |
$282.04 Billion | $282.04 Billion | USA | $187.03 | -1.43% | +1.12% | 43.91 Million |
| 9 |
Novartis AG ADR
NYSE:NVS |
$281.41 Billion | $281.41 Billion | USA | $147.48 | +0.11% | -3.02% | 34.68 Million |
| 10 |
Roche Holding AG
SW:ROG |
$256.43 Billion | CHF202.83 Billion | Switzerland | CHF320.70 | +0.79% | -8.76% | 28.40 Million |
| 11 |
AstraZeneca PLC
F:ZEGA |
$252.57 Billion | €216.04 Billion | Germany | €75.50 | -3.82% | -2.58% | 3.45K |
| 12 |
Roche Holding AG
SW:ROP |
$250.86 Billion | CHF198.42 Billion | Switzerland | CHF364.70 | +1.96% | -0.87% | 20.28 Million |
| 13 |
AstraZeneca PLC
NYSE:AZN |
$250.46 Billion | $250.46 Billion | USA | $161.50 | +3.78% | -6.37% | 88.71 Million |
| 14 |
Novartis AG
SW:NOVN |
$216.30 Billion | CHF171.09 Billion | Switzerland | CHF124.46 | -0.11% | -4.56% | 55.50 Million |
| 15 |
Amgen Inc
NASDAQ:AMGN |
$198.99 Billion | $198.99 Billion | USA | $407.83 | +4.57% | +3.75% | 58.37 Million |
| 16 |
Gilead Sciences Inc
NASDAQ:GILD |
$163.47 Billion | $163.47 Billion | USA | $131.76 | -2.58% | -1.91% | 163.14 Million |
| 17 |
Novo Nordisk A/S
CO:NOVO-B |
$155.26 Billion | Dkr992.33 Billion | Denmark | Dkr294.30 | -4.32% | -12.25% | 98.98 Million |
| 18 |
Pfizer Inc
SA:PFIZ34 |
$147.67 Billion | R$752.56 Billion | Brazil | R$33.09 | -0.78% | -2.25% | 179.03K |
| 19 |
Pfizer Inc
NYSE:PFE |
$147.10 Billion | $147.10 Billion | USA | $25.81 | +1.57% | +2.22% | 911.94 Million |
| 20 |
Bristol-Myers Squibb Company
NYSE:BMY |
$114.68 Billion | $114.68 Billion | USA | $63.63 | -3.43% | +0.05% | 255.36 Million |
| 21 |
GlaxoSmithKline PLC ADR
NYSE:GSK |
$111.15 Billion | $111.15 Billion | USA | $55.63 | -0.13% | -3.77% | 93.36 Million |
| 22 |
GlaxoSmithKline plc
MX:GSKN |
$106.48 Billion | MX$1.85 Trillion | Mexico | MX$922.00 | -2.95% | +1.87% | 3.47K |
| 23 |
Sanofi
F:SNW2 |
$104.50 Billion | €89.39 Billion | Germany | €36.80 | +0.00% | -3.66% | 0.00 |
| 24 |
Sanofi
MX:SNYN |
$102.08 Billion | MX$1.77 Trillion | Mexico | MX$741.00 | +0.00% | -3.77% | 8.30K |
| 25 |
GSK PLC SP. ADR/2 NEW
F:GS70 |
$101.34 Billion | €86.68 Billion | Germany | €47.20 | +0.00% | -3.28% | 120.00 |
| 26 |
Sanofi SA
PA:SAN |
$95.70 Billion | €81.86 Billion | France | €74.50 | +0.15% | -6.15% | 53.66 Million |
| 27 |
Roche Holding AG
SW:RO |
$49.91 Billion | CHF39.48 Billion | Switzerland | CHF370.00 | +1.87% | -0.96% | 520.15K |
| 28 |
Bayer AG NA
XETRA:BAYN |
$36.43 Billion | €31.16 Billion | Germany | €49.22 | +2.01% | +4.66% | 55.83 Million |
| 29 |
Biogen Inc
NASDAQ:BIIB |
$27.74 Billion | $27.74 Billion | USA | $206.63 | -0.87% | +0.50% | 32.59 Million |
| 30 |
ASTELLAS PHARMA UNSP.ADR
F:YPHA |
$19.55 Billion | €16.72 Billion | Germany | €12.90 | +0.00% | -3.73% | 2.40K |
| 31 |
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SHG:600436 |
$12.08 Billion | CN¥82.55 Billion | China | CN¥136.83 | -0.49% | +0.60% | 232.41 Million |
| 32 |
CSPC PHARMACEUT.GR. ADR4
F:CVGU |
$11.04 Billion | €9.44 Billion | Germany | €3.52 | +0.00% | -6.38% | 45.00 |
| 33 |
CSPC Pharmaceutical Group Limited
F:CVG |
$10.04 Billion | €8.59 Billion | Germany | €0.90 | -0.56% | -1.03% | 0.00 |
| 34 |
Sichuan Kelun Pharmaceutical Co Ltd
SHE:002422 |
$9.99 Billion | CN¥68.24 Billion | China | CN¥42.90 | +1.44% | -5.11% | 1.16 Billion |
| 35 |
Orion Oyj B
HE:ORNBV |
$8.48 Billion | €7.25 Billion | Finland | €81.85 | +1.80% | +1.36% | 4.25 Million |
| 36 |
ORION CORP.B UNSP.ADR 1/2
F:OFK0 |
$8.31 Billion | €7.10 Billion | Germany | €36.20 | -1.09% | -0.55% | 40.00 |
| 37 |
Grifols S.A.
MC:GRF |
$5.04 Billion | €4.31 Billion | Spain | €10.21 | +0.10% | +2.22% | 49.82 Million |
| 38 |
GlaxoSmithKline Pharmaceuticals Limited
NSE:GLAXO |
$4.71 Billion | Rs435.32 Billion | India | Rs2569.70 | -2.92% | -2.39% | 1.74 Million |
| 39 |
Grifols S.A
F:G0FB |
$4.42 Billion | €3.78 Billion | Germany | €6.80 | +2.26% | +3.03% | 0.00 |
| 40 |
GRIFOLS ADR 1/2/EO-50
F:G0F |
$4.21 Billion | €3.60 Billion | Germany | €4.26 | -2.74% | -1.84% | 192.00 |
| 41 |
Organon & Co
NYSE:OGN |
$3.52 Billion | $3.52 Billion | USA | $13.57 | +0.07% | +0.37% | 52.14 Million |
| 42 |
Orion Oyj A
HE:ORNAV |
$3.03 Billion | €2.59 Billion | Finland | €81.40 | +1.50% | +1.12% | 150.25K |
| 43 |
Virbac SA
PA:VIRP |
$3.01 Billion | €2.58 Billion | France | €338.50 | +0.15% | -2.03% | 123.89K |
| 44 |
Pfizer Limited
NSE:PFIZER |
$2.43 Billion | Rs224.53 Billion | India | Rs4908.00 | +0.94% | +6.15% | 721.21K |
| 45 |
AstraZeneca PLC
LSE:AZN |
$2.27 Billion | GBX18.67 Trillion | UK | GBX12036.00 | +2.52% | -6.61% | 82.58 Million |
| 46 |
Kalbe Farma Tbk PT
JK:KLBF |
$2.12 Billion | Rp36.25 Trillion | Indonesia | Rp800.00 | +8.84% | +14.29% | 1.94 Billion |
| 47 |
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
SHE:300357 |
$1.85 Billion | CN¥12.62 Billion | China | CN¥24.10 | -0.74% | +4.01% | 285.87 Million |
| 48 |
Yifan Xinfu Pharmaceutical Co Ltd
SHE:002019 |
$1.82 Billion | CN¥12.43 Billion | China | CN¥10.22 | -1.26% | +2.40% | 376.66 Million |
| 49 |
Aurora Optoelectronics Co Ltd
SHG:600666 |
$1.58 Billion | CN¥10.81 Billion | China | CN¥3.93 | +3.97% | +20.55% | 3.16 Billion |
| 50 |
Zhejiang Jolly Pharmaceutical Co Ltd
SHE:300181 |
$1.45 Billion | CN¥9.90 Billion | China | CN¥14.11 | -1.54% | +1.00% | 574.95 Million |
| 51 |
Cosmo Pharmaceuticals N.V
F:C43 |
$1.28 Billion | €1.09 Billion | Germany | €63.90 | +0.31% | -5.05% | 2.28K |
| 52 |
COSMO Pharmaceuticals SA
SW:COPN |
$1.28 Billion | CHF1.01 Billion | Switzerland | CHF60.60 | +1.51% | -3.81% | 826.52K |
| 53 |
SANOFI CONS HEALTHC IND L
NSE:SANOFICONR |
$1.13 Billion | Rs104.82 Billion | India | Rs4551.40 | +0.49% | -3.31% | 322.83K |
| 54 |
GuangYuYuan Chinese Herbal Medicine Co Ltd
SHG:600771 |
$1.03 Billion | CN¥7.03 Billion | China | CN¥14.37 | -1.44% | +0.56% | 257.18 Million |
| 55 |
NanJing Pharmaceutical Co Ltd
SHG:600713 |
$969.18 Million | CN¥6.62 Billion | China | CN¥5.06 | -0.98% | +1.20% | 383.93 Million |
| 56 |
GlaxoSmithKline PLC
LSE:GSK |
$936.14 Million | GBX7.69 Trillion | UK | GBX1915.50 | +0.05% | -5.59% | 130.65 Million |
| 57 |
Sanofi India Limited
NSE:SANOFI |
$829.00 Million | Rs76.66 Billion | India | Rs3328.40 | -1.94% | -1.03% | 683.42K |
| 58 |
Hunan Jingfeng Pharmaceutical
SHE:000908 |
$799.47 Million | CN¥5.46 Billion | China | CN¥6.21 | +0.00% | -0.96% | 985.60 Million |
| 59 |
Chongqing Lummy Pharmaceutical
SHE:300006 |
$778.75 Million | CN¥5.32 Billion | China | CN¥5.04 | -0.79% | -0.40% | 848.33 Million |
| 60 |
Zhejiang Int'L Group Co Ltd
SHE:000411 |
$727.04 Million | CN¥4.97 Billion | China | CN¥9.52 | -0.83% | +1.71% | 110.56 Million |
| 61 |
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.
SHE:301096 |
$663.32 Million | CN¥4.53 Billion | China | CN¥41.50 | +1.94% | +7.26% | 105.29 Million |
| 62 |
SENORES PHARMACEUTICALS L
NSE:SENORES |
$659.07 Million | Rs60.94 Billion | India | Rs1323.30 | -2.73% | -0.05% | 7.57 Million |
| 63 |
Hangzhou Minsheng Healthcare Co Ltd
SHE:301507 |
$634.97 Million | CN¥4.34 Billion | China | CN¥12.17 | -0.73% | +2.87% | 96.55 Million |
| 64 |
Shandong Keyuan Pharmaceutical Co. Ltd. A
SHE:301281 |
$586.31 Million | CN¥4.01 Billion | China | CN¥37.00 | +2.55% | +4.25% | 100.33 Million |
| 65 |
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd
SHG:600671 |
$393.11 Million | CN¥2.69 Billion | China | CN¥22.06 | -0.50% | +7.14% | 142.18 Million |
| 66 |
Dimed S.A. Distribuidora de Medicamentos
SA:PNVL3 |
$363.18 Million | R$1.85 Billion | Brazil | R$12.42 | -0.16% | +7.07% | 17.04 Million |
| 67 |
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A
SHG:600613 |
$346.49 Million | CN¥2.37 Billion | China | CN¥4.94 | -1.59% | +1.86% | 239.43 Million |
| 68 |
Zhejiang Zhenyuan Share Co Ltd
SHE:000705 |
$320.25 Million | CN¥2.19 Billion | China | CN¥6.55 | -1.80% | +2.99% | 159.07 Million |
| 69 |
Amarin Corporation PLC
NASDAQ:AMRN |
$302.16 Million | $302.16 Million | USA | $14.41 | +0.07% | +3.30% | 1.58 Million |
| 70 |
Hubei Guangji Pharmaceutical Co Ltd
SHE:000952 |
$297.85 Million | CN¥2.04 Billion | China | CN¥5.87 | -1.34% | +6.53% | 209.69 Million |
| 71 |
Guangdong Jiaying Pharmaceutical Co Ltd
SHE:002198 |
$251.76 Million | CN¥1.72 Billion | China | CN¥3.39 | +1.50% | +6.94% | 180.19 Million |
| 72 |
NGL Fine-Chem Limited
NSE:NGLFINE |
$229.05 Million | Rs21.18 Billion | India | Rs3428.20 | +5.22% | +6.73% | 211.62K |
| 73 |
TTK Healthcare Limited
NSE:TTKHLTCARE |
$159.83 Million | Rs14.78 Billion | India | Rs1045.90 | +0.79% | -0.21% | 646.71K |
| 74 |
Daishin Balance No.6 Special Purpose Acquisition Co. Ltd
KQ:307750 |
$73.96 Million | ₩109.13 Billion | Korea | ₩2175.00 | +0.93% | +11.14% | 3.11 Million |
| 75 |
PharmGen Science Inc
KO:004720 |
$48.19 Million | ₩71.11 Billion | Korea | ₩3245.00 | -2.41% | -0.92% | 887.74K |
| 76 |
Scilex Holding Company
NASDAQ:SCLX |
$45.86 Million | $45.86 Million | USA | $6.52 | +0.77% | -4.40% | 4.57 Million |
| 77 |
Singbao International Co Ltd
TWO:6130 |
$35.47 Million | NT$1.13 Billion | Taiwan | NT$23.80 | +0.00% | -2.66% | 9.19 Million |
| 78 |
Nasus Pharma Ltd.
NYSE MKT:NSRX |
$33.96 Million | $33.96 Million | USA | $2.90 | +1.05% | -2.36% | 2.69 Million |
| 79 |
MIRA Pharmaceuticals, Inc. Common Stock
NASDAQ:MIRA |
$27.54 Million | $27.54 Million | USA | $0.66 | -2.56% | -21.68% | 2.10 Million |
| 80 |
Yung Zip Chemical Ind Co Ltd
TWO:4102 |
$25.50 Million | NT$809.34 Million | Taiwan | NT$19.10 | +0.26% | -1.80% | 1.80 Million |
| 81 |
Korean Drug Co. Ltd
KQ:014570 |
$24.72 Million | ₩36.48 Billion | Korea | ₩3370.00 | -0.30% | +2.28% | 127.77K |
| 82 |
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B
SHG:900904 |
$24.58 Million | $24.58 Million | China | $0.45 | +0.00% | +2.75% | 3.56 Million |
| 83 |
BCWORLD PHARM. Co. Ltd
KQ:200780 |
$22.10 Million | ₩32.61 Billion | Korea | ₩3190.00 | +0.16% | +1.27% | 287.82K |
| 84 |
Lipidor Ab
ST:LIPI |
$18.82 Million | Skr174.88 Million | Sweden | Skr0.22 | +0.00% | +0.00% | 0.00 |
| 85 |
Medicus Pharma Ltd. Common Stock
NASDAQ:MDCX |
$16.82 Million | $16.82 Million | USA | $0.30 | -2.37% | +6.00% | 36.52 Million |
| 86 |
Chorokbaem Healthcare Co Ltd
KO:118000 |
$15.48 Million | ₩22.85 Billion | Korea | ₩1330.00 | +2.78% | +4.72% | 1.09 Million |
| 87 |
Firebrick Pharma Ltd
AU:FRE |
$4.84 Million | AU$6.83 Million | Australia | AU$0.02 | +0.00% | -11.11% | 2.78 Million |
Track real-time market capitalization of largest public companies in the Drug Manufacturers - General industry. Compare marketcap, analyze stock performance, and discover leading drug manufacturers - general corporations. View all industries